List of Figures:
Figure 2-1: Stem Cell Therapy Development Process
Figure 2-2: Stem Cell Market (Million US$), 2008-2012
Figure 2-3: Forecast for Stem Cell Market by Region (%), 2012
Figure 3-1: Therapeutic Banking Market (Million US$), 2007-2012
Figure 3-2: Cellular Therapeutics Market (Million US$), 2007-2012
Figure 3-3: Stem Cell Product Sales (Million US$), 2007-2012
Figure 3-4: Adult Stem Cell Product Market (Million US$), 2008-2012
Figure 4-1: Patients Suffering from Spinal Cord Injury (Million), 2006, 2008 & 2009
Figure 4-2: Patients Suffering from Myocardial Infarction (Million), 2006 & 2008
Figure 5-1: Cord Blood Bank Market (Million US$), 2007 & 2010
Figure 5-2: Share of US in Global Cord Blood Bank Market (2007)
Figure 5-3: Cord Blood Inventory in Public and Private Banks (Million), H1 2008
Figure 5-4: Cord Blood Inventory in Public Banks by Place (Million), H1 2008
List of Tables:
Table 4-1: Stem Cell Therapy Market Potential in Spinal Cord Injury (2009)
Table 5-1: Potential Patient Population for Stem Cell Therapy by Medical Condition (Million)
Table 5-2: Annual Direct Expenditures for Selected Diseases (Billion US$)
Table 5-3: Stem Cell Therapy Cost Comparison to Leading Treatment (Million US$)
Table 6-1: Funding of Stem Cell Research in Different States (2004-2007)
Table 7-1: Stem Cells Inc. - Strengths and Weaknesses
Table 7-2: Aastrom Biosciences Inc – Strengths and Weaknesses
Table 7-3: Brainstorm Cell Therapeutics – Strengths and Weaknesses
Table 7-4: Thermogenesis Corp – Strengths and Weaknesses
